Stocks and Investing Stocks and Investing
Wed, December 19, 2012
Tue, December 18, 2012

Market Maker Surveillance Report. HEB, MO, GE, GERN, JCP, CLWR, Highest Net Sell Volume and Negative Price Friction For Tuesda


Published on 2012-12-18 18:01:32 - WOPRAI
  Print publication without navigation


December 18, 2012 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Tuesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Tuesday there were 3909 companies with "abnormal" market making, 3872 companies with positive Friction Factors and 2053 companies with negative Friction Factors. Here is a list of the top companies with the highest net sell volume on Tuesday and lowest negative price Friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. Hemispherx Biopharma Inc (AMEX:HEB), Altria Group Inc (NYSE:MO), General Electric Co (NYSE:GE), Geron Corp (NASDAQ:GERN), J C Penney Company Inc (NYSE:JCP), Clearwire Corp (NASDAQ:CLWR). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

  Symbol  Change    Percent   Buy Volume   Buy %%    Sell Volume  Sell %%   Net Volume   Friction
  HEB     $-0.270   -42.55%   5,746,825    28.14%    7,766,964    38.03%    -2,020,139   -74,820 
  MO      $-0.390   -1.18%    4,508,264    21.10%    11,673,115   54.65%    -7,164,851   -183,714
  GE      $-0.240   -1.09%    24,162,095   29.90%    28,531,658   35.31%    -4,369,563   -182,065
  GERN    $-0.120   -7.06%    1,158,858    27.64%    2,863,283    68.30%    -1,704,425   -142,035
  JCP     $-0.470   -2.28%    2,344,311    24.37%    4,465,482    46.42%    -2,121,171   -45,131 
  CLWR    $-0.050   -1.72%    34,718,192   45.57%    41,367,345   54.30%    -6,649,153   -1,329,831
Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have low price friction combined with more selling than buying (negative Net Volume) in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows HEB down $-0.27000 with a Friction Factor of -74,820 and a Net Volume of -2,020,139. That means that it takes 74,820 more shares of selling than buying to drop HEB by one penny. On Monday the Market Makers allowed the stock to move down on heavier selling than buying (low negative friction).

Hemispherx Biopharma Inc (AMEX:HEB) - Hemispherx Biopharma, Inc., a specialty pharmaceutical company, engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders. The companys products include Ampligen, an experimental drug that is under clinical development for the treatment of myalgic encephalomyelitis/chronic fatigue syndrome, Hepatitis B, human immunodeficiency virus, renal cell carcinoma, and malignant melanoma; and Alferon N Injection for the treatment of genital warts. Its products also comprise Alferon LDO, a low-dose, oral liquid formulation of natural alpha interferon for influenza and other emerging viral diseases; and Oragens, a set of oral broad spectrum antivirals and immunological enhancers for the treatment of chronic viral and immunological disorders. The company has a strategic alliance with Accredo to develop certain marketing and distribution capacities for Ampligen in the United States. Hemispherx Biopharma, Inc. was founded in 1990 and is headquartered in Philadelphia, Pennsylvania..

Altria Group Inc (NYSE:MO) - Altria Group, Inc., through its subsidiaries, engages in the manufacture and sale of cigarettes, wine, and other tobacco products in the United States and internationally. It primarily offers cigarettes under the Marlboro, Virginia Slims, and Parliament brands; smokeless tobacco products under the Copenhagen, Skoal, Red Seal, and Husky brands, as well as Marlboro snus; and machine-made large cigars and pipe tobacco. The company also maintains a portfolio of leveraged and direct finance leases principally in transportation, including aircraft, as well as power generation and manufacturing equipment, and facilities. It serves wholesalers, including distributors; large retail organizations, such as chain stores; and the armed services. The company was founded in 1919 and is headquartered in Richmond, Virginia..

General Electric Co (NYSE:GE) - General Electric Company (GE) operates as a technology, media, and financial services company worldwide. Its Energy Infrastructure segment produces gas, steam, and aero derivative turbines; generators; combined cycle systems; and renewable energy solutions, as well as provides water treatment services and equipment. This segment also sells surface and subsea drilling and production systems, floating production platform equipment, compressors, turbines, turboexpanders, and high pressure reactors to oil and gas companies. The companys Technology Infrastructure segment manufactures jet engines, turboprop and turbo shaft engines, and its replacement parts for use in military and commercial aircraft, as well as provides repair and maintenance services. This segment also produces healthcare products, including diagnostic imaging systems; offers transportation products and maintenance services; provides enterprise solutions using sensors for temperature, pressure, moisture, gas and flow rate, as well as non-destructive testing inspection equipment. GEs NBC Universal segment engages in the production and distribution of films and television programs; operation of television stations and cable/satellite television networks, as well as theme parks. The companys Capital Finance segment offers commercial lending and leasing products to manufacturers, distributors, and end-users of equipment and capital assets; consumer financial services to consumers and retailers; capital and investment solutions for real estate; commercial finance to the energy and water industries; and commercial aircraft leasing and finance, and fleet and financing solutions. Its Consumer & Industrial segment produces various home appliances, lighting products, and electrical equipment and control products, as well as provides related services. The company has a joint venture with Shenhua International Limited. The company was founded in 1892 and is based in Fairfield, Connecticut..

Geron Corp (NASDAQ:GERN) - Geron Corporation, a biopharmaceutical company, develops biopharmaceuticals for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure, and diabetes. It develops a range of anti-cancer therapies based on telomerase inhibitors and telomerase therapeutic vaccines; and diagnostics based on telomerase detection, as well as intends to develop products using telomerase as a marker for cancer diagnosis, prognosis, patient monitoring, and screening. The company develops Imetelstat (GRN163L), which is in Phase I clinical trial for the treatment of chronic lymphoproliferative diseases, solid tumors, multiple myeloma, and non-small cell lung cancer. GRN163L is also in Phase I/II clinical trial to treat breast cancer. The company also develops GRNVAC1 that is in Phase II clinical trial for the treatment of acute myelogenous leukemia. It also develops GRNOPC1, which is in Phase I Trial for treatment of spinal cord injury; and GRNCM1 that is in preclinical stage to treat heart disease and screening. The company has licensing agreement with Merck & Co. to develop telomerase cancer vaccine, which is in Phase I clinical trial for the treatment of prostate and solid tumors; Sienna Cancer Diagnostics to develop a preclinical stage product for the treatment of bladder cancer; and has a collaboration with the University Campus Suffolk to develop human embryonic stem cell-derived chondrocytes for the treatment of cartilage damage and joint disease. Geron Corporation was founded in 1990 and is based in Menlo Park, California..

J C Penney Company Inc (NYSE:JCP) - J. C. Penney Company, Inc., through its subsidiary, J. C. Penney Corporation, Inc., operates a network of department stores in the United States and Puerto Rico. It sells family apparel and footwear, accessories, fine and fashion jewelry, beauty products, and home furnishings. The company also provides various services, such as styling salon, optical, portrait photography, and custom decorating. It sells its products through department stores and catalogs, as well as through the Internet at jcp.com. As of January 30, 2010, the companys distribution network included 13 merchandise distribution centers, 5 regional warehouses, and 4 direct fulfillment centers. As of March 29, 2010, it operated 1,100 department stores. The company was founded in 1902 and is based in Plano, Texas..

Clearwire Corp (NASDAQ:CLWR) - Clearwire Corporation, through its subsidiaries, builds and operates mobile broadband networks that provide high-speed residential and mobile Internet access services and residential voice services in communities in the United States. It offers wireless broadband and mobile broadband services, as well as voice over Internet protocol telephony services for homes and offices. The company also leases residential modems, as well as sells modems and personal computer cards. As of December 31, 2009, the company operated in 61 markets in the United States and Europe, covering an estimated 44.7 million people, and had approximately 642,000 retail and 46,000 wholesale subscribers. It markets its products and services directly to consumers, as well as through cellular retailers, consumer electronics stores, satellite television dealers, and computer sales and repair stores. Clearwire Corporation also markets its products and services through company-operated retail outlets. The company, formerly known as WiMAX Operations of Sprint Nextel Corporation, is headquartered in Kirkland, Washington. Clearwire Corporation operates as a subsidiary of Sprint HoldCo, LLC..

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net

Contributing Sources